Apollomics Inc. Class A Ordinary Shares (APLM) is a publicly traded Healthcare sector company. As of November 6, 2026, APLM trades at $19.86 with a market cap of $49.50M and a P/E ratio of 0.00. APLM moved +0.00% today. Year to date, APLM is +28.70%; over the trailing twelve months it is -31.02%. Its 52-week range spans $3.66 to $42.12. Rallies surfaces APLM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Apollomics reports zero first-half revenue, $8.77 million loss and August financing: Apollomics’ first-half 2026 net loss narrowed 30% to $8.77 million, but revenue fell to zero from $8.5 million and cash was $1.01 million at June 30. An August 14 private placement generated about $8 million in cash proceeds and extinguished a $2 million convertible note; management identified substantial doubt about the company’s ability to continue as a going concern.
| Metric | Value |
|---|---|
| Price | $19.86 |
| Market Cap | $49.50M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $42.12 |
| 52-Week Low | $3.66 |
| Volume | 14.03K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
APLM analyst coverage data. Average price target: $0.00.